| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |